TAILIEUCHUNG - Regulator of G-protein Signaling (RGS)1 and RGS10 proteins as potential drug targets for neuroinflammatory and neurodegenerative diseases

Regulator of G-protein signaling (RGS) proteins were originally identified as negative regulators of G-protein-coupled receptor (GPCR) signaling via their GTPase-accelerating protein (GAP) activity. All RGS proteins contain evolutionarily conserved RGS domain; however, they differ in their size and regulatory domains. RGS1 and RGS10 are smaller than other RGS proteins, and their functions involve various inflammatory responses including autoimmune responses in both the periphery and the central nervous system (CNS). Neuroinflammation is the chronic inflammatory response in the CNS. Acute inflammatory response in the CNS is believed to be beneficial by involving the neuroprotective actions of immune cells in the brain, particularly microglia, to limit tissue damage and to aid in neuronal repair. However, chronically elevated levels of cytokines serve to maintain activation of abundant numbers of immune cells potentiating prolonged inflammatory responses and creating an environment of oxidative stress, which further hastens oxidative damage of neurons. In this review, we describe the implications and features of RGS proteins (specifically RGS1 and RGS10) in neuroinflammation and neurodegenerative diseases. | Regulator of G-protein Signaling RGS 1 and RGS10 proteins as potential drug targets for neuroinflammatory and neurodegenerative diseases

• Y khoa - Dược
• G protein coupled receptor
• Multiple sclerosis
• Parkinson’s disease
• Regulator of G protein signaling
• Neurodegenerative diseases
• Neural stem cells
• NSCs isolation
• Various neurodegenerative diseasesm
• Neural regeneration research
• BMC Cancer
• Autoimmune diseases
• Male infertility
• Inhibit disease progression
• Central nervous system
• Hydrogen sulphide
• Mitochondrial dysfunction
• Oxidative stress
• Scientific reports
• breast cancer
• medicine
• neurodegenerative
• Structural Biology
• intermediate cells
• Degenerative muscle diseases
• Human tooth germ stem cells
• Melatonin regulates
• Dulbecco’s modified Eagle’s medium
• BMC Genomics
• DNA methylation
• Histone modification
• Disease prevention
• Report medicine
• traditional medicine
• immune system
• Antimicrobial
• biosynthesis
• cancer
• cardiovascular
• neurodegenerative disorders
• Endothelium Aging
• Vascular Diseases
• Molecular Mechanisms
• Cellular Senescence
• Chronic Myelogenous Leukemia
• Colorectal Cancer
• Teratogenesi
• Medical Genetics
• Diagnostic Techniques
• Basic Genetics
• Experimental
• Numerical Methods
• Characterize Electrical
• Behaviour
• Carbon Fiber Composites
• Aeronautic Industry
• Case Based brain imaging
• Thoái hóa thần kinh
• White matter diseases
• Neurodegenerative Metabolic
• Developmental malformations
• Cranial nerves
• Histone deacetylase 6
• HDAC enzymes
• Inflammatory disorders
• C terminal zinc finger motif
• BMC Chemistry
• Adult onset neuronal ceroid lipofuscinosis
• Alzheimer’s disease
• Amyotrophic lateral sclerosis
• Caenorhabditis elegans
• Compound screening
• Frontotemporal dementia
• Huntington’s disease
• Clinical Neuroscience
• Foundations of Psychological
• Brain Diseases
• Neurocognitive disorders
• Brain Development
• Hepatosomatic index
• Megalobrama amblycephala
• Blunt snout bream
• Journal of Biology
• The apoptotic protease activating factor 1 (APAF1)
• Single nucleotide polymorphism (SNP)
• In silico
• Mitochondria dependent death pathway
• BMC Veterinary Research
• Multipotent mesenchymal stromal cells
• Mesenchymal stem cells
• Neural cellular lineages
• BMC Anesthesiology
• High fat diet
• Postoperative cognitive dysfunction
• Silent Information Regulator 1
• Obstetrics and Gynecology
• Prepregnancy Body
• Gestational Weight
• Birth Weight
• Maternal Immunity
• Genome Biology
• Neurodegenerative diseases
• Genome regulation
• Long noncoding RNAs
• Gene expression